Literature DB >> 27474033

Sunitinib-induced sudden hearing loss.

Kathleen Dekeister1, Emmanuelle Graillot2, Mickaël Durbec3, Jean-Yves Scoazec4, Thomas Walter2,5.   

Abstract

Entities:  

Keywords:  Hearing loss; Side effect; Sunitinib

Mesh：

Substances：

Year:  2016        PMID： 27474033     DOI： 10.1007/s10637-016-0378-z

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN： 0167-6997            Impact factor:   3.850


× No keyword cloud information.
  6 in total

1.  Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma.

Authors:  Carlos Frangié; Carmen Lefaucheur; Jacques Medioni; Christian Jacquot; Garry S Hill; Dominique Nochy
Journal:  Lancet Oncol       Date:  2007-02       Impact factor: 41.316

2.  Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome.

Authors:  E Kapiteijn; A Brand; J Kroep; H Gelderblom
Journal:  Ann Oncol       Date:  2007-10       Impact factor: 32.976

3.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

4.  Sunitinib in combination with gemcitabine plus cisplatin for advanced non-small cell lung cancer: a phase I dose-escalation study.

Authors:  Martin Reck; Norbert Frickhofen; Susana Cedres; Ulrich Gatzemeier; David Heigener; Heinz-Georg Fuhr; Aron Thall; Silvana Lanzalone; Patricia Stephenson; Ana Ruiz-Garcia; Richard Chao; Enriqueta Felip
Journal:  Lung Cancer       Date:  2010-02-25       Impact factor: 5.705

5.  Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

Authors:  Eric Raymond; Laetitia Dahan; Jean-Luc Raoul; Yung-Jue Bang; Ivan Borbath; Catherine Lombard-Bohas; Juan Valle; Peter Metrakos; Denis Smith; Aaron Vinik; Jen-Shi Chen; Dieter Hörsch; Pascal Hammel; Bertram Wiedenmann; Eric Van Cutsem; Shem Patyna; Dongrui Ray Lu; Carolyn Blanckmeister; Richard Chao; Philippe Ruszniewski
Journal:  N Engl J Med       Date:  2011-02-10       Impact factor: 91.245

6.  Sunitinib combined with pemetrexed and cisplatin: results of a phase I dose-escalation and pharmacokinetic study in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer and mesothelioma.

Authors:  D Ross Camidge; Normand Blais; Derek J Jonker; Denis Soulières; Robert C Doebele; Ana Ruiz-Garcia; Aron Thall; Ke Zhang; Scott A Laurie; Richard C Chao; Laura Q Chow
Journal:  Cancer Chemother Pharmacol       Date:  2012-10-30       Impact factor: 3.333
  6 in total
  1 in total

Review 1.  Water Waves to Sound Waves: Using Zebrafish to Explore Hair Cell Biology.

Authors:  Sarah B Pickett; David W Raible
Journal:  J Assoc Res Otolaryngol       Date:  2019-01-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.